Saxenda vs Wegovy
Drug comparison
Last updated 2026-05-28 15:46 UTCSaxenda (liraglutide) and Wegovy (semaglutide) are both injectable prescription medications made by Novo Nordisk for treating obesity. Saxenda is approved solely for weight management, while Wegovy is also approved to reduce cardiovascular risk in people with obesity. Both are given as once-daily shots under the skin, but they contain different active ingredients.
AI summary of the sources below.
| Saxenda | Wegovy | |
|---|---|---|
| Active ingredient | liraglutide | semaglutide |
| Manufacturer | novo-nordisk | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | obesity | obesity, cardiovascular risk reduction |
| Label updated | 2026-02-25 | 2026-05-05 |